Published On: April 29th, 2021Tags: , ,

Share

Published On: April 29th, 2021Tags: , ,

Share

Hemodialysis is a lifesaving procedure that requires a person to be connected to a dialysis machine by tubing that delivers fluid exchange. A vascular access is needed for this connection, with an arteriovenous fistula (AVF) or arteriovenous graft (AVG) being two common types of vascular access.  AVFs and AVGs typically are surgically created in a patient’s arm but often require procedures to either become functional (during maturation phase) or maintain function after first use (maintenance phase). Using data from the United States Renal Data System (USRDS), our researchers calculated access procedure (intervention) rates in the US for patients starting hemodialysis with an AVF or AVG created during their first year of hemodialysis therapy between July 1, 2012 and December 31, 2014 (N = 73,027). Subsequent access-related procedures were included in analyses through Dec. 31, 2016. Interventions were common for both AVFs and AVGs as the access matured, with 13,989 of 57,275 (24.4%) AVFs requiring a procedure (0.36 AVF procedures/patient) and 2,904 of 15,572 (18.4%) AVG patients requiring intervention (0.28 AVG procedures/patient during maturation. However, during the maintenance phase, procedure rates were considerably lower for AVFs (0.93 procedures/patient occurring in 40% of patients) than for AVGs (1.87 procedures/patient occurring in 58% of patients). Thus, during maturation, interventions are carried out in 18-24% of newly created AVFs and AVGs. Once successfully matured, AVF had 50% lower maintenance interventional requirements.

The full text is available here: https://www.ajkd.org/article/S0272-6386(21)00511-4/fulltext

Citation

Woodside KJ, Repeck KJ, Mukhopadhyay P, Schaubel DE, Shahinian VB, Saran R, Pisoni RL. Arteriovenous Vascular Access-Related Procedural Burden Among Incident Hemodialysis Patients in the United States. Am J Kidney Dis. 2021 Apr 12:S0272-6386(21)00511-4. doi: 10.1053/j.ajkd.2021.01.019. Epub ahead of print. PMID: 33857533.

Related Posts

  • Arbor Research is pleased to announce the appointment of Dr. Steve Hines, PhD as a Senior Research Scientist focusing on health services research and strategic partnerships. Dr. Hines brings a wealth of experience and expertise, having most recently led learning community activities for the AHRQ-funded TAKEheart project while his work updating AHRQ’s TeamSTEPPS training curriculum […]

  • Advancing the scientific understanding of kidney disease to inform healthcare practice and policy is at the core of Arbor Research’s history.  Founded in 1996 in Ann Arbor, Michigan by three leaders in chronic kidney disease care and research, we were originally named the University Renal Research and Education Association (URREA). Arbor Research’s first project was […]

  • The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program at Arbor Research Collaborative for Health is pleased to share their recent publication recognized as one of the most- downloaded articles at Kidney International Reports in the past few weeks titled “Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the […]

  • Arbor Research Collaborative for Health (Arbor Research) recently welcomed Dr. Ping Yu, as Chief Growth Officer. In his new role at Arbor Research, Dr. Yu will lead the Strategic Growth Team (SGT) to further expand Arbor Research’s growth initiatives. Dr. Yu brings a wealth of experience in health data, analytics, research, and evaluation, with a […]